Australia Aesthetic Devices Market Size, Share and Outlook - Growth Analysis Report and Forecast Trends (2026-2035)

Market Overview

The Australia aesthetic devices market is moving from rapid, lightly supervised expansion towards a more regulated and equipment-led phase. Clinics are replacing ageing single-purpose lasers with multi-platform systems, while regulators tighten who may operate them and how treatments are advertised.

Three forces are shaping the market: tougher practitioner and advertising rules, a push by suppliers towards ultrasound, radiofrequency and body contouring platforms, and growing demand for regenerative treatments, including among patients losing weight through medication.

In February 2025 the Therapeutic Goods Administration cancelled energy-based vaginal rejuvenation devices from the Australian Register of Therapeutic Goods. In September 2025 new Ahpra guidelines took effect, and in October 2025 ARPANSA highlighted gaps in cosmetic radiation rules.

Key Market Trends and Insights

• Tougher practitioner standards: Ahpra and the National Boards guidelines took effect on 2 September 2025, adding a seven-day cooling-off period for under-18s and stricter training expectations for those performing procedures.
• Regulatory gaps remain: ARPANSA said on 1 October 2025 that cosmetic radiation rules are inconsistent, with only three jurisdictions applying state-level controls to laser and light treatments.
• Strong supplier momentum: Sofwave reported first quarter 2026 revenue of USD 24.4 million, up 46%, while InMode reported USD 82.0 million, up 5%, in the same quarter.
• Product withdrawals: The TGA cancelled energy-based vaginal rejuvenation devices from the register in February 2025, showing that unproven claims can remove a product line quickly.

Australia Aesthetic Devices Market Size and Forecast

The market is shifting from standalone lasers and intense pulsed light towards integrated platforms that combine several energy sources, plus ultrasound and radiofrequency tools that need little downtime. Laser and light-based devices still lead in value, while body contouring and fat reduction advances fastest as clinics add non-invasive treatments for patients seeking alternatives to surgery. Medical spas and aesthetic clinics gain share as chains standardise equipment, and hospitals keep a steady role in higher-risk work. New South Wales remains the largest region, and Queensland grows quickest on tourism-linked and lifestyle demand. Compliance spending, practitioner training and device evidence requirements point to a durable change in purchasing behaviour rather than a short cycle.

Key Takeaways: Australia Aesthetic Devices Market

Regulation Raises the Bar for Equipment and Operators

Revenue is on course to more than double, from USD 410.00 million in 2025 to USD 901.69 million in 2035 at an 8.2% CAGR. Guidelines effective on 2 September 2025 and the TGA's February 2025 cancellation of vaginal rejuvenation devices favour suppliers with strong clinical evidence.

Non-Invasive Platforms Lead Growth

Laser and Light-Based Devices hold the largest share, but Radiofrequency and Ultrasound Devices grow at an estimated 9.6% CAGR and Body Contouring and Fat Reduction at an estimated 10.4% CAGR through 2035. Sofwave said in May 2026 that regenerative demand includes patients on GLP-1 therapies.

Compliance Is Now Part of the Purchase Decision

Clinics increasingly weigh training, evidence and advertising risk when choosing equipment, since regulators have narrowed what practitioners may claim and who may operate devices.

• Ahpra published two cosmetic guidelines in advance copy on 3 June 2025
• ARPANSA reported gaps in cosmetic radiation regulation on 1 October 2025
• Influencer testimonials for higher-risk procedures are barred from 2 September 2025

Australia Aesthetic Devices Market Report Summary

Key Insight

Demand is shifting towards non-invasive, multi-energy platforms as regulation tightens and clinics standardise equipment. New South Wales leads, and Queensland grows fastest across the forecast period.

Key Trends in the Australia Aesthetic Devices Market

The Australia aesthetic devices market is being reshaped by practitioner reforms, radiation safety scrutiny, regenerative treatment demand and multi-platform launches.

October 2025 - ARPANSA Flags Gaps in Cosmetic Radiation Regulation

• ARPANSA said on 1 October 2025 that regulation of cosmetic non-ionising radiation use is limited and inconsistent across Australia.
• Only Tasmania, Queensland and Western Australia apply state-level controls, and those cover only certain procedures.
• Clinics in other jurisdictions may see tighter operator and device rules if national uniformity is pursued.

September 2025 - Ahpra Cosmetic Procedure Guidelines Take Effect

• Guidelines for non-surgical cosmetic procedures and for advertising higher-risk procedures took effect on 2 September 2025.
• They require real, unedited images, identification of the practitioner and a seven-day cooling-off period for people under 18.
• Nurses and other practitioners must complete further training before expanding into these procedures, which affects who can operate devices.

June 2025 - Boards Publish Advance Copies of Two Cosmetic Guidelines

• Ahpra and the National Boards released the guidelines on 3 June 2025, three months before they applied.
• They replaced the Nursing and Midwifery Board's earlier position statement on nurses and cosmetic procedures.
• The notice period let clinics retrain staff and revise advertising before the September 2025 start.

February 2025 - TGA Cancels Energy-Based Vaginal Rejuvenation Devices from the Register

• MDA National reported in March 2025 that laser and radiofrequency devices for vaginal rejuvenation were cancelled in February 2025.
• The Therapeutic Goods Administration cited insufficient clinical evidence for therapeutic use and long-term safety.
• Devices for other purposes, such as dermatology, remain on the register, but unproven claims carry clear regulatory risk.

Key Insight

Practitioner reforms, radiation safety scrutiny and withdrawal of unproven device claims are the main structural forces, while uneven state rules remain the main source of uncertainty for clinics.

Recent Market Developments in the Australia Aesthetic Devices Market

Recent developments, presented from the most recent, show supplier results, injectable portfolio data, new platform launches and a restructured laser maker.

May 2026 - InMode and Sofwave Report First Quarter 2026 Results

• InMode reported on 6 May 2026 first quarter revenue of USD 82.0 million, up 5%, with international capital equipment down about 4%.
• Sofwave reported on 5 May 2026 revenue of USD 24.4 million, up 46%, and about 2,900 systems sold since launch.
• Sofwave linked demand to regenerative treatments, including patients on GLP-1 therapies, a trend relevant to Australian clinics.

April 2026 - AbbVie Reports Strong Botox Cosmetic Sales, Flat Juvederm

• AbbVie reported on 29 April 2026 Botox Cosmetic net revenues of USD 668 million, up 20.2%.
• Juvederm net revenues were USD 232 million, with international sales down 5.3% on a reported basis.
• Strong toxin demand supports device-led combination treatments in injector-led Australian clinics.

January 2026 - Candela Introduces Glace Skin Care System at IMCAS Paris

• Candela announced the European launch of its Glace professional facial skin-care platform at IMCAS Paris in January 2026.
• It also showed the Matrix radiofrequency platform and the Vbeam Pro vascular laser, launched in the United States in 2025.
• Skin-care add-ons give clinics a lower-risk entry into energy-based treatments under stricter practitioner rules.

November 2025 - Galderma Presents New Restylane and Sculptra Data at ASDS

• Galderma released data on 16 November 2025 for Restylane Lyft in chin augmentation and Sculptra after medication-driven weight loss.
• Restylane Skinboosters uses a SmartClick syringe system that gives audible feedback for precision.
• Injectable delivery tools and combination protocols widen the device-adjacent market for clinics.

Key Insight

Supplier results, new platform launches and injectable portfolio data show vendors positioning around regenerative, non-invasive and combination treatments that suit clinics operating under tighter regulatory expectations.

Australia Aesthetic Devices Industry Segmentation

The Expert Market Research’s report on the Australia Aesthetic Devices Market offers a detailed analysis of the market based on the following segments.

Market Breakup by Product Type

• Laser and Light-Based Devices
• Radiofrequency and Ultrasound Devices
• Body Contouring Devices
• Injectable Delivery and Skin Analysis Devices
• Others

Laser and Light-Based Devices lead on value, in our estimate, because clinics use them for resurfacing, pigmentation, vascular and hair work, as shown by Alma Harmony, launched in March 2025 with Q-Switch, fractional ablative, intense pulsed light and green diode options. Radiofrequency and Ultrasound Devices grow fastest at an estimated 9.6% CAGR through 2035, helped by Sofwave's 46% revenue rise in the first quarter of 2026. Body Contouring Devices grow steadily on non-surgical fat reduction demand. Injectable Delivery and Skin Analysis Devices grow with toxin and filler volumes, including AbbVie's Botox Cosmetic revenue of USD 668 million in April 2026.

Market Breakup by Application

• Skin Rejuvenation and Resurfacing
• Body Contouring and Fat Reduction
• Hair Removal
• Pigmentation and Vascular Treatment
• Others

Skin Rejuvenation and Resurfacing leads, in our estimate, because wrinkle, laxity and texture treatments suit multi-platform systems and ultrasound tools such as Sofwave. Body Contouring and Fat Reduction grows fastest at an estimated 10.4% CAGR through 2035, as clinics add non-surgical options for patients losing weight, a trend Sofwave raised in May 2026. Hair Removal remains a high-volume repeat service tied to laser and light systems. Pigmentation and Vascular Treatment benefits from launches such as Candela's Vbeam Pro, shown at IMCAS Paris in January 2026, though operator rules from September 2025 raise training costs.

Market Breakup by End User

• Dermatology and Plastic Surgery Clinics
• Medical Spas and Aesthetic Clinics
• Hospitals and Day Surgeries
• Others

Dermatology and Plastic Surgery Clinics lead, in our estimate, since specialist practitioners buy higher-priced lasers and meet the new training expectations that applied from 2 September 2025. Medical Spas and Aesthetic Clinics grow fastest at an estimated 9.2% CAGR through 2035, as chains standardise equipment and respond to the seven-day cooling-off rule for under-18s. Hospitals and Day Surgeries buy for reconstructive and higher-risk work and grow steadily. Others include training academies, mobile practitioners and research sites, which are affected by ARPANSA's October 2025 finding of uneven rules.

Market Breakup by Region

• New South Wales
• Victoria
• Queensland
• Western Australia
• Others

New South Wales dominates, in our estimate, because Sydney holds the densest cluster of cosmetic clinics and specialists, and it grows at an estimated 7.8% CAGR through 2035 from a large, mature base. Victoria grows at 8.0%, led by Melbourne's dermatology and plastic surgery clinics. Queensland is the fastest-growing region at an estimated 9.0%, on lifestyle demand and new clinic openings, although ARPANSA noted in October 2025 that it is one of three jurisdictions with state radiation controls. Western Australia grows at 8.6%. Others, covering the remaining states and territories, grow at 7.4% from smaller populations.

Purchase the Regional Overview for USD 1099

If you choose to purchase the full report at a later stage, the amount already paid will be adjusted, and you will only need to pay the remaining balance.

Purchase the Regional Overview for USD 1099

If you choose to purchase the full report at a later stage, the amount already paid will be adjusted, and you will only need to pay the remaining balance.

Competitive Landscape in the Australia Aesthetic Devices Market

Competition combines global energy-based device makers, injectable pharmaceutical groups with device-adjacent portfolios and local distributors serving clinics. Entry barriers include regulatory registration, clinical evidence, practitioner training, service networks and relationships with clinic chains.

InMode

InMode, headquartered in Yokneam, Israel, sells minimally invasive and non-invasive platforms for body contouring, skin tightening and rejuvenation, including radiofrequency-based systems, to clinics worldwide. On 6 May 2026 it reported first quarter revenue of USD 82.0 million, up 5%, and guided full-year 2026 revenue to USD 365 million to USD 375 million. International capital equipment revenue fell about 4%, which signals intense competition for clinic budgets outside the United States.

Sofwave Medical

Sofwave Medical, an Israeli company listed on the Tel Aviv Stock Exchange, sells a non-invasive ultrasound platform for wrinkles and skin laxity, with United States operations in San Clemente, California. On 5 May 2026 it reported first quarter revenue of USD 24.4 million, up 46%, and about 2,900 systems sold. Its usage-fee model ties revenue to treatments performed, which suits clinics wanting predictable treatment economics.

Alma Lasers

Alma Lasers, headquartered in Caesarea, Israel, is a Sisram Medical company offering laser, intense pulsed light and energy-based aesthetic platforms. In March 2025 it launched Alma Harmony, combining Q-Switch, fractional ablative, non-ablative, intense pulsed light and green diode technologies, with up to 45% more energy than Harmony XL PRO under specific parameters. Multi-technology platforms help clinics treat many conditions with fewer devices.

AbbVie (Allergan Aesthetics)

AbbVie, headquartered in North Chicago, Illinois, owns Allergan Aesthetics, which sells Botox Cosmetic and Juvederm, products delivered by injectors who often also operate energy-based devices. On 29 April 2026 AbbVie reported Botox Cosmetic net revenues of USD 668 million, up 20.2%, and Juvederm net revenues of USD 232 million, with international sales down 5.3%. Strong toxin demand keeps injector-led clinics busy, supporting combination treatment protocols.

Other players operating in the Australia aesthetic devices market include Candela, Galderma, Cutera, Lumenis, and Cynosure Lutronic, alongside local distributors, service providers and smaller device importers supplying lasers, radiofrequency systems, body contouring equipment and skin analysis tools to clinics, hospitals and day surgeries across Australia.

Key Insight

Competition rests on clinical evidence, platform breadth, service reach and training support rather than price alone, while regulatory change favours suppliers with strong compliance records and clinic chain relationships.